Drug Discovery World

JUNE 7, 2023

The additional investment will support growth of the company’s proprietary RALA platform with an immediate focus on the advancement of pHion’s lead project, PTX_V1, into clinical trials in the first half of 2024. PTX_V1 is a first-in-class therapeutic vaccine for the treatment of human papilloma virus (HPV)-related cancers.

Vaccination 52

Vaccination Vaccine Drug Delivery Systems Drug Delivery 52

Roots Analysis

FEBRUARY 18, 2022

CLINICAL TRIALS EVALUATING MYELOID CELLS TAREGTING THERAPEUTICS. In the past decade, more than 1,500 clinical trials have been registered for evaluating drug therapies targeting myeloid cells. The key focus of these studies is on the development of anti-tumor therapeutics. Our Social Media Platform. Web: [link].

Drug Delivery Systems 52

Drug Delivery Systems Immune Response Clinical Trials Clinical Trials 52

Roots Analysis

FEBRUARY 14, 2023

Broad Clinical Trial Landscape Till date, close to 800 clinical studies evaluating various liposome-based therapeutics have been initiated worldwide. Further, the most targeted disease area within oncological disorders is ovarian cancer, with 226 clinical trials registered in the given time period.

Development 52

Development Manufacturing Drug Delivery Systems Contract Manufacturing 52

Pharmaceutical Technology

NOVEMBER 7, 2022

SHL Medical is a world-leading solutions provider for advanced drug delivery systems with a unified purpose to further enable patient independence. Finding the necessary talent to fill the company’s new facility is not expected to be a problem. Sustainable, advanced manufacturing in Charleston.

Production 130

Production Life Science Manufacturing Drug Delivery Systems 130

XTalks

MAY 30, 2023

XTALKS WEBINAR: Drug Delivery — Addressing Global Regulatory Challenges in Co-Packaged, On-Body Systems Live and On-Demand: Thursday, June 15, 2023, at 10am EDT (4pm CEST/EU-Central) Register for this free webinar to learn about on-body drug delivery systems and addressing their complex global regulatory requirements.

Drug Delivery 98

Drug Delivery Drug Delivery Systems Manufacturing Contamination 98

Roots Analysis

MARCH 2, 2022

With four commercialized therapies and over 120 clinical / preclinical development programs, oral protein and peptide therapies represent a lucrative segment of the pharmaceutical industry. Oral Protein / Peptide-based Drugs. Clinical Research Landscape of Oral Peptide and Protein-based Therapeutics. Our Social Media Platform.

Protein 52

Protein Drug Delivery Drugs Drug Delivery Systems 52

Roots Analysis

MARCH 16, 2022

Broad Clinical Trial Landscape. Till date, over 180 clinical studies which primarily include completed, ongoing and planned trials evaluating various clinical research activity related to exosomes and involving nearly 2,392 patients enrolled across different centers / hospitals, have been initiated worldwide.

Marketing 59

Marketing Manufacturing Drug Delivery Drug Delivery Systems 59

Roots Analysis

MAY 21, 2024

The coupling of chemotherapeutic agents with LNPs leads to an increase in the drug levels in tumor tissue and decreases the active therapeutic dose, resistance of drugs and toxicity. The LNPs can be monitored using various imaging modalities to confirm the delivery of siRNA to the target cells.

Drug Delivery 40

Drug Delivery Drugs Gene Therapy Bioavailability 40

Drug Discovery World

OCTOBER 19, 2022

At each stage, there is a continued process of attrition that ultimately limits the number of new APIs making it to the clinical phases, and approximately 90% of new drug candidates advancing to clinical trials fail to achieve final drug approval 2,3. . Consider drug delivery systems early on .

Drug Delivery 52

Drug Delivery Drugs Drug Delivery Systems Development 52

XTalks

MAY 23, 2024

XTALKS WEBINAR: Enhancing Efficiency in Early-Phase Oncology Trials: Strategies for Accelerating Data Flow Live and On-Demand: June 24, 2024, at 11am EDT (4pm BST/UK) Register for this webinar today to gain insights into how you can navigate and overcome data flow challenges in early-phase oncology clinical trials.

Life Science 72

Life Science Dermatology Drug Delivery Systems Medicine 72

Roots Analysis

MARCH 3, 2022

Broad Clinical Trial Landscape. Till date, more than 870 clinical studies evaluating various complement-targeted therapeutics and involving nearly 2,430,000 patients enrolled across different centers / hospitals, have been initiated worldwide. Next Generation Complement Therapeutics. Our Social Media Platform. Web: [link].

Drug Delivery Systems 52

Drug Delivery Systems Marketing Immune Response Dermatology 52

XTalks

NOVEMBER 4, 2021

Related: Genentech’s New Ocular Implant Drug Delivery System for Macular Degeneration Could Be a Game Changer. Vuity’s formula is fast-acting, working as quickly as 15 minutes after administration and lasting for up to six hours. Importantly, it improves near and intermediate vision without affecting distance vision.

FDA Approval 98

FDA Approval Drug Delivery Systems Trials Drug Delivery 98

Delveinsight

NOVEMBER 29, 2020

Therapies such as dexamethasone drug delivery system and vascular endothelial growth factor inhibitors have already pierced deeper into the market. Looking at its potential, the drug is also being watched out in diabetic macular edema in combination with intravitreal anti-VEGF drugs.

Marketing 52

Marketing Pharma Companies Drug Delivery Clinical Trials 52

Roots Analysis

SEPTEMBER 1, 2023

The platform utilizes electronic health records (EHRs) to generate real-world datasets that can be used to identify outcomes for those typically underrepresented or not represented in clinical trials. Streamlining Supply Chain Management The digital field is making a relevant move in the pharmaceutical industry in more than one field.

Drug Delivery 52

Drug Delivery Marketing Drug Delivery Systems Drugs 52

The Pharma Data

AUGUST 31, 2021

S ites and Burden of Metastases and Long-Term Outcomes in TITAN Patients (moderated poster session) : Assessment of relationships between the number and location of metastases and oncological outcomes in 1,052 patients with metastatic castration-sensitive prostate cancer (mCSPC) enrolled in the TITAN trial (Abstract #MP24-08). About TAR-200.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Trials Drugs 52

XTalks

AUGUST 30, 2022

Filipe Rodrigues, MD/MSc, Medical Director at Medpace spoke about the modern-day applications of direct CNS administration, including intrathecal, intraparenchymal and ICV delivery. Vornov, the use of intrathecal delivery in drug development is unexplored for small molecules and peptides besides what has already been proved.

Trials 83

Trials Drug Delivery Drugs Gene 83